Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06243887

Implementing Enhanced Recovery After Surgery (ERAS) Protocol in Patients Undergoing Minimal Invasive Esophagectomy

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
15 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Detect impact of enhanced recovery after surgery (ERAS) on the outcomes of oesophageal surgery .

Detailed description

esophagectomy for both malignant and benign disease has been identified as a particularly complex surgical procedure due to documented high levels of peri-operative morbidity and mortality. A comprehensive review of complications associated with the esophagectomies performed in high-volume esophageal units utilizing a standardized format for documenting complications and quality measures has confirmed an overall complication rate of 59 % with 17.2% of patients sustaining complications of IIIb or greater utilizing the Clavien-Dindo severity grading system. post-operative complications include high rate of anastomotic leakage , pulmonary infection ,thoracic duct injury , voice changes , breathlessness ,long hospital stay. These outcomes accentuate the need for providing an enhanced recovery after surgery standardized format for esophagectomy which can be routinely applied and audited to improve international outcomes. though ERAS lacking randomized control trials

Conditions

Interventions

TypeNameDescription
OTHEREnhanced Recovery After Surgery (ERAS) protocol in minimal invasive esophagectomyEnhanced Recovery After Surgery (ERAS) refers to patient-centered, evidence-based, multidisciplinary team developed pathways for a surgical specialty and facility culture to reduce the patient's surgical stress response, optimize their physiologic function, and facilitate recovery.
OTHERstandard of care approaches in minimal invasive esophagectomystandard of care approaches other than ERAS

Timeline

Start date
2024-04-01
Primary completion
2027-11-01
Completion
2027-12-01
First posted
2024-02-06
Last updated
2024-03-22

Source: ClinicalTrials.gov record NCT06243887. Inclusion in this directory is not an endorsement.